Latham & Watkins Represents Mobia Medical in US$150 Million IPO

Mobia Medical, Inc. (Nasdaq: MOBI) (Mobia Medical), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, priced its initial public offering of 10 million shares of its common stock at a public offering price of US$15.00 per share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and other offering expenses payable by Mobia Medical, were approximately US$150 million, excluding any exercise of the underwriters’ option to purchase additional shares. Mobia Medical’s common stock began trading on the Nasdaq Global Select Market under the ticker symbol MOBI on May 8, 2026. Mobia Medical granted the underwriters a 30-day option to purchase up to an additional 1.5 million shares of common stock at the initial public offering price, less underwriting discounts and commissions.

Latham & Watkins LLP represented Mobia Medical in the offering with a corporate team led by partners Shayne Kennedy and Ross McAloon, with associates Jacob Walsh, Rachel Staub, and Tony Noh. Advice was also provided on executive compensation matters by partner Holly Bauer; on FDA regulatory matters by partner Elizabeth Richards; on healthcare regulatory matters by partner Betty Pang; on data privacy and cyber security matters by partner Heather Deixler; on IP matters by counsel Robert Yeh; and on tax matters by partner Eric Cho.